Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H24FN3O2 |
| Molecular Weight | 357.4219 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(CCN1C=NC2=C1C=CC=C2)NCC(O)C3=CC=C(O)C=C3F
InChI
InChIKey=KOTMQCNDGLTIHR-UHFFFAOYSA-N
InChI=1S/C20H24FN3O2/c1-20(2,9-10-24-13-22-17-5-3-4-6-18(17)24)23-12-19(26)15-8-7-14(25)11-16(15)21/h3-8,11,13,19,23,25-26H,9-10,12H2,1-2H3
| Molecular Formula | C20H24FN3O2 |
| Molecular Weight | 357.4219 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Nardeterol (SOM-1122) was found to be a high-affinity, partial agonist for beta adrenergic receptors. SOM-1122 inhibited the binding of [125I]iodopindolol to membranes prepared from rat cerebral cortex and cerebellum. SOM-1122 bound to beta adrenergic receptors in vitro and in vivo, increased levels of cyclic AMP in slices of cerebral cortex in vitro and reduced the density of beta adrenergic receptors after chronic treatment. SOM-1122 also was found to be behaviorally active. It reduced locomotor activity
and altered behavior maintained under DRL and multiple FlFR schedules. These behavioral effects of SOM-1122 are similar
to those reported previously for other centrally acting beta
adrenergic agonists.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Formation of oedema and accumulation of eosinophils in the guinea pig lung. Inhibition by inhaled beta-stimulants. | 1989 |
|
| Psychopharmacological consequences of activation of beta adrenergic receptors by SOM-1122. | 1988-07 |
|
| Discriminative stimulus properties of clenbuterol: evidence for beta adrenergic involvement. | 1988-04 |
Patents
Sample Use Guides
Groups of 10 rats each were used to determine the effects of SOM-1122 (0.003-3 mg/kg) on behavior maintained
under DRL and multiple Fl-FR schedules and to determine the ability of propranolol (1 mg/kg) to antagonize the effects of SOM-1122. For all behavioral experiments, SOM-1122 was dissolved in 0.9% NaCl and administered i.p.
at a volume of 1 ml/kg b.w.
Route of Administration:
Intraperitoneal
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:05:19 GMT 2025
by
admin
on
Mon Mar 31 18:05:19 GMT 2025
|
| Record UNII |
70859437W3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
73865-18-6
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105150
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY | |||
|
SUB09165MIG
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY | |||
|
68918
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY | |||
|
6513
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY | |||
|
70859437W3
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY | |||
|
C76541
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY | |||
|
100000080341
Created by
admin on Mon Mar 31 18:05:19 GMT 2025 , Edited by admin on Mon Mar 31 18:05:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
